8-K: Predictive Oncology Sets 2025 Annual Meeting Date
Annual Meeting Announcement
Predictive Oncology Inc. announced the date and record date for its 2025 annual meeting of stockholders, along with the deadline for shareholder proposals.
Summary
- Predictive Oncology Inc. will hold its 2025 annual meeting of stockholders on November 25, 2025.
- The meeting will take place at the offices of DLA Piper LLP (US) at 1001 Liberty Avenue, Suite 500, Pittsburgh, Pennsylvania 15222.
- The record date for stockholders entitled to notice and vote at the Annual Meeting is October 24, 2025.
- Stockholders have until October 26, 2025, to submit proposals and request proxy access for any business to be considered at the Annual Meeting.
- The company anticipates mailing definitive proxy materials for the Annual Meeting on or about November 3, 2025.
- The Annual Meeting is scheduled more than 30 days from the date of the company's 2024 annual meeting of stockholders.
Sentiment
Score: 5
Explanation: The filing is a routine administrative announcement regarding the annual meeting and shareholder proposal deadlines, carrying a neutral sentiment.
Future Outlook
The company anticipates mailing definitive proxy materials for the Annual Meeting on or about November 3, 2025, and undertakes to supplement such materials and potentially postpone the meeting if stockholder proposals are timely received.
Industry Context
This announcement is a routine corporate governance event, common across all publicly traded companies, ensuring compliance with regulatory requirements for shareholder engagement and annual meetings.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Scheduling | Announcement of the 2025 annual meeting of stockholders, including date, time, and location. | 2025-11-25 | Ensures compliance with corporate bylaws and SEC regulations for shareholder engagement and director nominations. |
| Shareholder Proposal Deadline | Establishment of the deadline for stockholders to submit proposals and request proxy access for the 2025 Annual Meeting. | 2025-10-26 | Provides a clear timeline for shareholders to exercise their rights to propose business or nominate directors, adhering to SEC rules. |
Stakeholder Impact
- Shareholders: Provides critical dates for participation in the annual meeting, including voting and submitting proposals.
Next Steps
- Mailing of definitive proxy materials on or about November 3, 2025.
- Holding the 2025 annual meeting of stockholders on November 25, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-10-16 | Date of Report (earliest event reported) |
| 2025-10-24 | Record date for stockholders entitled to notice of, and to vote at, the Annual Meeting |
| 2025-10-26 | Proposal Deadline for stockholders to submit proposals and request proxy access |
| 2025-11-03 | Anticipated mailing date for definitive proxy materials for the Annual Meeting |
| 2025-11-25 | Date of the 2025 annual meeting of stockholders |
Keywords
Predictive Oncology, POAI, Annual Meeting, Shareholder Meeting, Proxy, Corporate Governance, SEC Filing, 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.